How do we improve the treatment of stroke patients in the future?



This educational supplement has been sponsored by MicroVention.

Since its inception in 1997, MicroVention has gradually expanded its offerings from cerebral aneurysms to include several other areas in neuroendovascular care—with ischaemic stroke being a key area of focus over the past 15 years. Among the more than 30 products the company has launched to date are the well-established ERIC family of stent retrievers, the SOFIA Plus aspiration catheter and, more recently, the BOBBY balloon guide catheter.

In this educational supplement, a number of esteemed neurointerventionists from across the globe have endeavoured to not only share experiences with these devices, either through daily usage in their centres or as part of clinical studies, but also to provide insights on wider considerations in the treatment of acute ischaemic stroke. These discussions range from health economics analyses, and the importance of real-world evidence in medical device evaluation, to the need for more open-minded philosophies in neurointerventional surgery.


Please enter your comment!
Please enter your name here